This study represents a rigorous, multi-state evaluation that highlights the impact of a charitable medication access program on hospital utilization for the medically under-served population.
This study represents a rigorous, multi-state evaluation that highlights the impact of a charitable medication access program on hospital utilization for the medically under-served population.
In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it
Medication non-adherence has led to at least 100,000 preventable deaths each year and $100 billion annually in preventable healthcare costs in the United States
The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023
How Many People Might Lose Medicaid When States Unwind Continuous Enrollment?
FDA approves 1 Year delay of Track & Trace requirements
We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…
Branson MO: My Neighbor’s Charitable Pharmacy (NCP) will open its doors at 1232 Branson Hills Parkway February of 2023
Using Public Health Detailing to Increase Access and Confidence in COVID-19 Vaccines and Reinvest in Disproportionately Impacted NYC Communities Go…
Uninsured adults and those in worse health continue to report higher rates of not getting care due to costs
NOVA ScriptsCentral is excited to collaborate with the American Pharmacist Association to launch the “NOVA ScriptsCentral & American Pharmacist Association Safety-Net Health Equity Fellowship”.
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.
NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.
Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected

